(Q34370981)

1 August 2017

1 reference

title

Management of negative symptoms of schizophrenia (English)

1 reference

1 August 2017

0 references

Javitt DC

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Current Psychiatry Reports

1 August 2017

published in

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

413-417

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-996-0036-9

1 August 2017

exact match

0 references

cites work

Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-996-0036-9

Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-996-0036-9

Associated deficits in mismatch negativity generation and tone matching in schizophrenia

21 January 2018

1 reference

12 December 2020

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

1 reference

12 December 2020

Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients

1 reference

12 December 2020

Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome.

1 reference

12 December 2020

Behavioral effects of chronic phencyclidine in monkeys

1 reference

12 December 2020

Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys

1 reference

12 December 2020

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

12 December 2020

A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group

1 reference

12 December 2020

Concurrent validity of negative symptom assessments in treatment refractory schizophrenia: relationship between interview-based ratings and inpatient ward observations

1 reference

12 December 2020

Memory and executive function impairments in deficit syndrome schizophrenia

1 reference

12 December 2020

Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.

1 reference

12 December 2020

Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS).

1 reference

12 December 2020

1 reference

12 December 2020

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

1 reference

12 December 2020

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

1 reference

12 December 2020

Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study

1 reference

12 December 2020

Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern

1 reference

12 December 2020

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

1 reference

12 December 2020

Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions

1 reference

12 December 2020

Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

1 reference

12 December 2020

Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia

1 reference

12 December 2020

Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale

1 reference

12 December 2020

A separate disease within the syndrome of schizophrenia

1 reference

12 December 2020

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

1 reference

12 December 2020

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

1 reference

12 December 2020

Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release

1 reference

12 December 2020

Placebo-controlled trial of glycine added to clozapine in schizophrenia

1 reference

12 December 2020

Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test.

1 reference

12 December 2020

A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder

1 reference

12 December 2020

1 reference

12 December 2020

Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque

1 reference

12 December 2020

Single doses of MK-801, a non-competitive antagonist of NMDA receptors, increase the number of 5-HT1A serotonin receptors in the rat brain.

1 reference

12 December 2020

Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

1 reference

12 December 2020

The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia.

1 reference

12 December 2020

10.1007/S11920-996-0036-9

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1013365264

0 references

1 reference